RS92704A - Molekuli prepoznavanja ćelijske površine koji sadrže imunoglobulinski domen - Google Patents

Molekuli prepoznavanja ćelijske površine koji sadrže imunoglobulinski domen

Info

Publication number
RS92704A
RS92704A YU92704A YUP92704A RS92704A RS 92704 A RS92704 A RS 92704A YU 92704 A YU92704 A YU 92704A YU P92704 A YUP92704 A YU P92704A RS 92704 A RS92704 A RS 92704A
Authority
RS
Serbia
Prior art keywords
seq
polypeptide
nucleic acid
disease
acid molecule
Prior art date
Application number
YU92704A
Other languages
English (en)
Serbian (sr)
Inventor
Andrew Robert Davids
Richard Joseph Fagan
Christopher Benjamin Phelps
Christine Power
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of RS92704A publication Critical patent/RS92704A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
YU92704A 2002-04-30 2003-04-30 Molekuli prepoznavanja ćelijske površine koji sadrže imunoglobulinski domen RS92704A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0209884.6A GB0209884D0 (en) 2002-04-30 2002-04-30 Proteins
PCT/GB2003/001851 WO2003093316A2 (en) 2002-04-30 2003-04-30 Immunoglobulin-domain containing cell surface recognition molecules

Publications (1)

Publication Number Publication Date
RS92704A true RS92704A (sr) 2006-12-15

Family

ID=9935806

Family Applications (1)

Application Number Title Priority Date Filing Date
YU92704A RS92704A (sr) 2002-04-30 2003-04-30 Molekuli prepoznavanja ćelijske površine koji sadrže imunoglobulinski domen

Country Status (16)

Country Link
US (1) US7622555B2 (enExample)
EP (1) EP1499640A2 (enExample)
JP (1) JP2006502702A (enExample)
KR (1) KR20050008699A (enExample)
CN (1) CN1665840A (enExample)
AU (1) AU2003229961B2 (enExample)
BR (1) BR0309638A (enExample)
CA (1) CA2483038A1 (enExample)
EA (1) EA007985B1 (enExample)
GB (1) GB0209884D0 (enExample)
IL (1) IL164777A0 (enExample)
MX (1) MXPA04010674A (enExample)
NO (1) NO20044628L (enExample)
RS (1) RS92704A (enExample)
WO (1) WO2003093316A2 (enExample)
ZA (1) ZA200408453B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0326393D0 (en) * 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
WO2006120160A1 (en) * 2005-05-06 2006-11-16 Laboratoires Serono S.A. Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases
CN100402551C (zh) * 2006-04-14 2008-07-16 中国科学院长春应用化学研究所 β2-微球蛋白的抗原表位及应用
BRPI0716060A2 (pt) 2006-08-17 2013-09-17 Boehringer Ingelheim Int inibidores de polimerase viral.
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US7906117B2 (en) 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
ES2721753T3 (es) 2007-05-21 2019-08-05 Alderbio Holdings Llc Anticuerpos contra IL-6 y usos de los mismos
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
WO2011066371A2 (en) 2009-11-24 2011-06-03 Alder Biopharmaceuticals, Inc. Antibodies to il-6 and use thereof
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
WO2012071561A2 (en) 2010-11-23 2012-05-31 Alder Biopharmaceuticals, Inc. Anti-il-6 antibodies for the treatment of anemia
CN107526942B (zh) * 2017-07-18 2021-04-20 中山大学 生命组学序列数据的反向检索方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
GB2331666A (en) * 1997-11-20 1999-05-26 Dsc Telecom Lp Subscriber Terminal for a Wireless Telecommunications System
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
AU2001233041A1 (en) * 2000-01-25 2001-08-07 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002034783A2 (en) * 2000-10-27 2002-05-02 Incyte Genomics, Inc. Transmembrane proteins
CA2429195A1 (en) * 2000-11-16 2002-05-23 Incyte Genomics, Inc. Immunoglobulin superfamily proteins
WO2004007672A2 (en) 2002-07-12 2004-01-22 Nuvelo, Inc. Methods and materials relating to novel polypeptides and polynucleotides
AU2003303305A1 (en) 2002-10-02 2004-09-30 Nuvelo,Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
AU2003229961B2 (en) 2009-02-19
EA200401453A1 (ru) 2005-06-30
IL164777A0 (en) 2005-12-18
ZA200408453B (en) 2006-07-26
CA2483038A1 (en) 2003-11-13
KR20050008699A (ko) 2005-01-21
BR0309638A (pt) 2005-03-01
EA007985B1 (ru) 2007-02-27
US7622555B2 (en) 2009-11-24
CN1665840A (zh) 2005-09-07
NO20044628L (no) 2004-12-29
WO2003093316A3 (en) 2004-02-12
WO2003093316A2 (en) 2003-11-13
JP2006502702A (ja) 2006-01-26
US20040204352A1 (en) 2004-10-14
MXPA04010674A (es) 2005-02-17
EP1499640A2 (en) 2005-01-26
AU2003229961A1 (en) 2003-11-17
GB0209884D0 (en) 2002-06-05

Similar Documents

Publication Publication Date Title
RS92704A (sr) Molekuli prepoznavanja ćelijske površine koji sadrže imunoglobulinski domen
US20090324562A1 (en) Defensin Proteins
IL182749A (en) Vwfa and/or ant_ig domain containing proteins
JP2005532034A (ja) 分泌タンパク質
WO2008047111A1 (en) Immunoglobulin domain-containing cell surface recognition molecules
JP2005528336A (ja) シスチン−ノットフォールドタンパク質
EP1802653B1 (en) Mam domain containing protein
MX2007001543A (es) Glucoproteina de superficie celular.
US20090215672A1 (en) Cys-Rich, Cell Surface Glycoproteins
AU2003241006B2 (en) TNF-like secreted protein
WO2008001045A1 (en) Members of the glycoside hydrolase family 31 family of proteins
JP2006526386A (ja) Ｉｌ−８様タンパク質
US20080199435A1 (en) IL-8 Like Protein
WO2003100061A2 (en) Three finger toxin fold proteins
WO2004000882A2 (en) Proteins
WO2004009624A2 (en) Three finger toxin fold protein
KR20060035601A (ko) Ｔｎｆ-유사 분비 단백질
CA2436334A1 (en) Adhesion molecules
WO2007045891A1 (en) Kunitz domain containing protein